首页> 外文期刊>Cancer Growth and Metastasis >New Insight on the Role of Plasminogen Receptor in Cancer Progression
【24h】

New Insight on the Role of Plasminogen Receptor in Cancer Progression

机译:纤溶酶原受体在癌症进展中的作用的新见解

获取原文
           

摘要

Objective: Plasminogen system plays a crucial role in physiological and pathological events related to tissue regeneration, wound healing, immune response, angiogenesis, invasion and metastasis. It gets activated when plasminogen associates with its cell surface receptors. Latest information on some of the well-explored plasminogen receptors such as annexin II–S100A10, cytokeratin 8, α-enolase, plasminogen receptor (KT) (Plg-R(KT)) and histone H2B has been discussed in the present review. These receptors can pave the way for effective new therapeutic and diagnostic strategies to counteract malignant diseases.Conclusion: The present review concludes the key role of plasminogen receptors in extracellular matrix degradation, infiltration into surrounding tissues, neovascularization, invasion, metastasis and drug resistance. This review also discusses the possible effect of blocking these plasminogen receptors with monoclonal antibodies and DNA-based vaccination or silencing plasminogen receptor gene using small interfering RNA or short hairpin RNA to counteract cancer invasion and metastasis.
机译:目的:纤溶酶原系统在与组织再生,伤口愈合,免疫反应,血管生成,侵袭和转移有关的生理和病理事件中起着至关重要的作用。当纤溶酶原与其细胞表面受体结合时,它会被激活。在本综述中,已讨论了关于一些开发良好的纤溶酶原受体的最新信息,例如膜联蛋白II–S100A10,细胞角蛋白8,α-烯醇酶,纤溶酶原受体(KT)(Plg-R(KT))。这些受体可为抗击恶性疾病的有效新治疗和诊断策略铺平道路。这篇综述还讨论了使用小分子干扰RNA或短发夹RNA通过单克隆抗体和基于DNA的疫苗接种或沉默纤溶酶原受体基因阻断这些纤溶酶原受体的可能作用,以抵消癌症的侵袭和转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号